Novel Immunotherapeutics Summit 2013

The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity, immunotoxicity, allergy and asthma will be discussed at the summit.

• Keynote Speaker

Ron Levy

The summit includes the following 4 concurrent tracks as well as an optional pre-summit workshop held on Jan 30, 2013.

2nd Novel Immunotherapeutics Summit:

Workshop: Immune Responses in Tumor Microenvironment

Track: 5th Immunotherapeutics & Immunomonitoring

Track: 11th Cytokines & Inflammation

Track: 2nd Allergy & Respiratory Drug Discovery

Track: Immunogenicity & Immunotoxicity

Network with representatives from prestigious organizations and discuss the latest research from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk, Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme, Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San Francisco, and many more!